1. Academic Validation
  2. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

  • Proc Natl Acad Sci U S A. 2011 May 17;108(20):8426-31. doi: 10.1073/pnas.1019030108.
Andrew S Kondratowicz 1 Nicholas J Lennemann Patrick L Sinn Robert A Davey Catherine L Hunt Sven Moller-Tank David K Meyerholz Paul Rennert Robert F Mullins Melinda Brindley Lindsay M Sandersfeld Kathrina Quinn Melodie Weller Paul B McCray Jr John Chiorini Wendy Maury
Affiliations

Affiliation

  • 1 Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Abstract

The glycoproteins (GP) of enveloped viruses facilitate entry into the host cell by interacting with specific cellular receptors. Despite extensive study, a cellular receptor for the deadly filoviruses Ebolavirus and Marburgvirus has yet to be identified and characterized. Here, we show that T-cell Ig and Mucin domain 1 (TIM-1) binds to the receptor binding domain of the Zaire Ebola virus (EBOV) glycoprotein, and ectopic TIM-1 expression in poorly permissive cells enhances EBOV Infection by 10- to 30-fold. Conversely, reduction of cell-surface expression of TIM-1 by RNAi decreased Infection of highly permissive Vero cells. TIM-1 expression within the human body is broader than previously appreciated, with expression on mucosal epithelia from the trachea, cornea, and conjunctiva--tissues believed to be important during in vivo transmission of filoviruses. Recognition that TIM-1 serves as a receptor for filoviruses on these mucosal epithelial surfaces provides a mechanistic understanding of routes of entry into the human body via inhalation of aerosol particles or hand-to-eye contact. ARD5, a monoclonal antibody against the IgV domain of TIM-1, blocked EBOV binding and Infection, suggesting that Antibodies or small molecules directed against this cellular receptor may provide effective Filovirus antivirals.

Figures